Publications by authors named "Enrico Mura"
An annotation-independent algorithm based on electrogram characteristics to guide the identification of ventricular tachycardia isthmuses in patients with structural heart disease.
J Interv Card Electrophysiol
June 2024
Background: Criteria such as electrograms voltage or late potentials have been largely utilized in the past to help identify areas of substrate maps that are within the ventricular tachycardia (VT) isthmus; yet their specificity and positive predictive value are quite low. The Lumipoint fractionation tool of the Rhythmia system illuminates regions with fractionated electrograms irrespective of their timing and annotation. We aimed to ascertain whether the use of this tool can rapidly identify areas within VT isthmuses from substrate maps.
View Article and Find Full Text PDFPlatelet inhibition with orodispersible ticagrelor in acute coronary syndromes according to morphine use: the TASTER study final results.
Eur Heart J Cardiovasc Pharmacother
December 2023
Article Synopsis
- The study aims to investigate whether orodispersible tablet (ODT) ticagrelor can effectively inhibit platelet aggregation in acute coronary syndrome (ACS) patients who are also receiving morphine, comparing it to the standard coated tablet form.
- A total of 130 ACS patients were randomly assigned to receive either ODT or standard ticagrelor loading doses, with assessments made regarding platelet reactivity after treatment, particularly looking for any interaction effects with morphine.
- The results showed that while morphine-treated patients had higher platelet reactivity one hour after the loading dose, there were no significant differences in platelet reactivity between the ODT and standard ticagrelor groups, nor were there significant differences in adverse events related to
Background: VDD pacemakers are regarded as a second choice in patients with atrio-ventricular blocks mainly due to the potential failure of atrial sensing, leading to a loss of atrio-ventricular synchrony. This single-centre study aimed to evaluate the prevalence of loss of atrial sensing and its potential determinants in patients with VDD pacemakers.
Method: 142 patients with an implanted VDD device underwent long-term follow-up with clinical evaluation, electrocardiogram, device interrogation and echocardiogram.